Events

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 14th Annual International Meeting

As ISPOR President, Chris Pashos, ABS Vice President, addressed the conference on Monday, May 18.

ABS was both an exhibitor at the conference and an event sponsor.

In addition, we led a four-hour Patient Registries Short Course on Sunday, May 17. Dr. Pashos, Mason Russell, ABS Vice President, Kay Larholt, ABS Vice President, and Neal Mantick, ABS Executive Director, were featured speakers.

Monday, May 18, 2009

PODIUM SESSION II

CO2	METHODS FOR INTERPRETING AND DISPLAYING RESULTS FROM REGRESSION MODELS: BEYOND BETAS AND ODDS RATIOS M Ganz

POSTER PRESENTATIONS SESSION I

PCN7	CLINICAL AND ECONOMIC OUTCOMES IN CANCER CHEMOTHERAPY PATIENTS INITIATED ON ERYTHROPOIESIS STIMULATING AGENTS (ESA) AT HEMOGLOBIN (HB) LEVELS <10 G/DL T Burton, K Larholt, E Apgar, CL Pashos, RS McKenzie, CT Piech
PCN61	THE ECONOMIC BURDEN OF METASTATIC BREAST CANCER T Foster, JD Miller, ME Boye, MB Blieden, V Ancukiewicz, MW Russell
PGI18	EXAMINING PROTON PUMP INHIBITOR (PPI) TREATMENT PATTERNS AMONG PATIENTS WITH SELECTED UPPER GASTROINTESTINAL CONDITIONS MC De Leon, R Mody, L Boulanger
PMS6	DEVELOPMENT OF TESTS FOR DIAGNOSIS OF RHEUMATOID ARTHRITIS L Schiff, T Foster, J Creeden, J Gartemann, J Hsieh, CL Pashos
PSS13	OUTCOMES OF CATARACT PATIENTS WITH ASTIGMATISM: IMPLANTATION OF TORIC VERSUS CONVENTIONAL MONOFOCAL INTRAOCULAR LENS S Denevich, WC Lee, C Waycaster, S Pennie, M Ganz, CL Pashos
PSS23	PHYSICIANS' AWARENESS, ATTITUDE, AND BEHAVIOR TO USE THE WAIT AND WATCH APPROACH FOR THE TREATMENT OF ACUTE OTITIS MEDIA PZ Donga, RK Goyal, SS Sansgiry

Tuesday, May 19, 2009

PATIENT REGISTRY SIG FORUM

Patient Registry Design, Operations, Data Analysis, Reporting & Publishing: Putting All the Pieces Together — this session focused on classification, characteristics, design, implementation, and operation of registries as well as the analysis, use and publication of registry data.

Speakers:

Chris L. Pashos, Vice President, Abt Bio-Pharma Solutions, Inc.
Eric Gemmen, Executive Director, Analytics & Health Outcomes, Quintiles Drug Safety & Medical Affairs
Chris Blanchette, Director, Lovelace Respiratory Research Institute
Shital Kamble, Research Assistant, University of North Carolina
Diana Frame, Consultant, Frame Research
Maria Malmenäs, Manager Biostatistics, Outcome Surveys, Global Medical Affairs, Shire Human Genetic Therapies
Mike Novotny, CEO, Medrio
Marg Hux, Lead Analyst, Health Economics & Outcomes, i3Innovus

PODIUM SESSION III

ND4	COST-UTILITY OF INTERFERON BETA-B IN THE TREATMENT OF PATIENTS WITH A CLINICALLY ISOLATED SYNDROME SUGGESTIVE OF MULTIPLE SCLEROSIS: MODEL UTILIZING FIVE YEAR BENEFIT DATA JP Caloyeras, B Harrow, C Wang, K Beckmann, V Knappertz, C Pohl, JD Miller, MW Russell, R Sandbrink, K Gondek

POSTER PRESENTATIONS SESSION II

PDB28	EXCESS COSTS OF DIABETES MELLITUS AMONG MEDICARE RECIPIENTS IN A SKILLED NURSING FACILITY SETTING L Boulanger, JH Kongsø, JR Bouchard, T Christensen, K Fraser, MW Russell
PDB32	CHANGES IN OPIOID USE AND ECONOMIC OUTCOMES AMONG DIABETIC PERIPHERAL NEUROPATHIC PAIN PATIENTS TREATED WITH DULOXETINE L Boulanger, N Wu, SY Chen, K Fraser, Y Zhao
PDB54	DULOXETINE THERAPY AND CHANGES IN OPIOID USE AMONG DIABETIC PERIPHERAL NEUROPATHIC PAIN PATIENTS N Wu, Y Zhao, L Boulanger, K Fraser, SY Chen
PIN30	ACUTE CARE COSTS OF GRAM-NEGATIVE PNEUMONIA IN THE UNITED STATES: A HEALTHCARE COST AND UTILIZATION PROJECT (HCUP) DATA ANALYSIS A Smalarz, WC Lee, CL Pashos, S Pennie, K Wittrup-Jensen

Wednesday, May 20, 2009

POSTER PRESENTATIONS SESSION III

PCV5	DEVELOPMENT OF TESTS FOR EARLY DIAGNOSIS OF PREECLAMPSIA L Schiff, T Foster, J Creeden, W Van der Helm, J Gartemann, CL Pashos
PCV17	ASSOCIATION BETWEEN PHARMACY TREATMENT AND OUTCOMES IN PATIENTS WITH CHRONIC HEART FAILURE DH Shah, SJ Agarwal, CM Ashton, ML Johnson
PCV30	THE ASSOCIATION OF ASPIRIN USE ON RISK OF HOSPITALIZATION IN CHF PATIENTS TAKING ACE INHIBITORS: A RETROSPECTIVE ANALYSIS OF A NATIONAL COHORT OF VETERANS NM Parikh, DH Shah, A Deswal, CM Ashton, SJ Agarwal, H Chen, M Johnson
PCV73	INCREASED PATIENT THROUGHPUT AND REDUCTION IN LABORATORY STAFF AND LABOR INTENSITY WITH THE USE OF REGADENOSON AM Smalarz, S Denevich, L Boulanger, J Spaulding
PND14	COST OF PSEUDOMONAS AERUGINOSA IN CYSTIC FIBROSIS PATIENTS IN THE UNITED KINGDOM AM Smalarz, B Harrow, O Schoeman, K Uhl-Hochgraeber, CL Pashos